Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence

Human Immunology

Volumn 72, Issue 4, 2011, Pages 337-341

  Ferguson, Rhea ^a   Ramanakumar, Agnihotram V ^a   Richardson, Harriet ^b   Tellier, Pierre Paul ^a   Coutlée, François ^c   Franco, Eduardo L ^a   Roger, Michel ^c,d  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Genetic variants; HLA E; HLA G; HPV susceptibility and persistence

Indexed keywords

HLA E ANTIGEN; HLA G ANTIGEN;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANADA; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; UNIVERSITY STUDENT; WART VIRUS;

EID: 79952627197     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.01.010     Document Type: Article

References (17)

1. Trottier H., Franco E.L. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(suppl 1):S1-S15.
2. Franco E.L., Villa L.L., Sobrinho J.P., Prado J.M., Rousseau M.C., Désy M., et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999, 180:1415-1423.
3. de Araujo Souza P.S., Sichero L., Maciag P.C. HPV variants and HLA polymorphisms: the role of variability on the risk of cervical cancer. Future Oncol 2009, 5:359-370.
4. Ashrafi G.H., Haghshenas M.R., Marchetti B., O'Brien P.M., Campo M.S. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005, 113:276-283.
5. Mahmud S.M., Robinson K., Richardson H., Tellier P.P., Ferenczy A.S., Roger M., et al. HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal University students. J Infect Dis 2007, 196:82-90.
6. Richardson H., Kelsall G., Tellier P., Voyer H., Abrahamowicz M., Ferenczy A., et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003, 12:485-490.
7. Coutlee F., Gravitt P., Richardson H., Hankins C., Franco E., Lapointe N., et al. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. The Canadian Women's HIV study group. J Clin Microbiol 1999, 37:1852-1857.
8. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
9. Halloran M.E., Struchiner C.J. Causal inference in infectious diseases. Epidemiology 1995, 6:142-151.
10. Yoon B.S., Kim Y.T., Kim J.W., et al. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynecol Obstet 2007, 98:48-53.
11. Goncalves M.A., Le Discorde M., Simoes R.T., Rabreau M., Soares E.G., Donadi E.A., et al. Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2008, 141:70-74.
12. Matte C., Lajoie J., Lacaille J., Zijenah L.S., Ward B.J., Roger M. Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 2004, 18:427-431.
13. Clements C.S., Kjer-Nielsen L., Kostenko L., Hoare H.L., Dunstone M.A., Moses E., et al. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 2005, 102:3360-3365.
14. Sim'es R.T., Goncalves M.A., Castelli E.G., Júnior C.M., Bettini J.S., Discorde M.L., et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol 2009, 22:1075-1082.
15. Rouas-Freiss N., Moreau P., Menier C., Carosella E.D. HLA-G in cancer: a way to turn off the immune system. Semin Cancer Biol 2003, 13:325-336.
16. Ristich V., Zhang W., Liang S., Horuzsko A. Mechanisms of prolongation of allograft survival by HLA-G/ILT4-modified dendritic cells. Hum Immunol 2007, 68:264-271.
17. Ristich V., Liang S., Zhang W., Wu J., Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005, 35:1133-1142.